Emily G Rejcek, PA
Physician Assistant · Fremont
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 5 years
- Graduated 2021
On the public record
- California licence: Revoked
- 2 Medical Board actions on record
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Emily G Rejcek’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G60533 · Revoked
Licence status: Revoked · since 1987 · University of Minnesota Medical School. Board flags: Revoked.
License has been revoked as a result of disciplinary action rendered by the Board. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
Public record actions
| 2004-08-18 | Board disciplineDiscipline | Revoked. · 16 2003153041 |
| 2003-10-16 | Action in another state or by a federal agencyDiscipline | Effective 10/16/03 oregon board assessed a fine. · Oregon board of medical examiners |
Original Medicare doctor bills
$1,578
Medicare paid this office $1,578 for 19 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of the uterus | 11 | More than 85% of doctors who do this |
Who their Medicare patients are
19 Original Medicare patients in 2024. Average age 68 · Health risk score 1.07. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 58%.
The office billed $6,271, Medicare allowed $2,411 and paid $1,578; for 22 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 19 | 22 | 68 | 1.07 | $6,271 | $1,578 |
| 2023 | 134 | 284 | 76 | 1.92 | $63,912 | $15,810 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 37 | $4,226 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,592 | $56 |
| Short return visit (20+ min) | 30 | $2,177 | $66 |
| New patient visit (45+ min) | 18 | $1,923 | $107 |
| Urinalysis, manual test | 43 | $167 | $3 |
| Manual urinalysis test with examination using microscope, non-automated | 18 | $71 | $4 |
Medicaid work
$5,020 in 2024
Medicaid paid $5,020 for 32 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 18 | $3,300 |
| Return visit (30+ min) | 14 | $1,720 |
| 2024 | 32 | 2 | 18 | $5,020 |
Drugs they prescribed that Part D paid
$101,360
Pharmacies billed $101,360 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
971 generic and 111 brand-name prescriptions · $101,360 in drug cost · 153 antibiotic prescriptions to 107 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 96 | $58,993 | $615 |
| Tamsulosin | 338 | $5,147 | $15 |
| Mirabegron Er | 11 | $4,175 | $380 |
| Estradiol | 81 | $3,832 | $47 |
| Methenamine Hippurate | 26 | $2,076 | $80 |
See all 16 drugs
| Myrbetriq | 96 | $58,993 | $615 |
| Tamsulosin | 338 | $5,147 | $15 |
| Mirabegron Er | 11 | $4,175 | $380 |
| Estradiol | 81 | $3,832 | $47 |
| Methenamine Hippurate | 26 | $2,076 | $80 |
| Finasteride | 127 | $1,877 | $15 |
| Terazosin | 37 | $1,530 | $41 |
| Fosfomycin Tromethamine | 13 | $1,361 | $105 |
| Solifenacin | 38 | $1,248 | $33 |
| Trospium Chloride | 42 | $708 | $17 |
| Oxybutynin Chloride Er | 20 | $559 | $28 |
| Nitrofurantoin Mono-Macro | 28 | $361 | $13 |
| Sulfamethoxazole-Trimethoprim | 41 | $239 | $6 |
| Cephalexin | 18 | $214 | $12 |
| Ciprofloxacin | 29 | $211 | $7 |
| Sildenafil Citrate | 17 | $65 | $4 |
Year by year
| 2024 | 1,097 | 528 | None | 10% | $101,360 |
| 2023 | 1,104 | 462 | None | None | $132,435 |
| 2022 | 24 | 15 | 0% (0) | None | $5,041 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Myrbetriq | 104 | $72,140 | $694 |
| Gemtesa | 18 | $15,061 | $837 |
| Solifenacin | 55 | $7,638 | $139 |
| Tamsulosin | 253 | $6,041 | $24 |
| Estradiol | 61 | $5,745 | $94 |
| Finasteride | 165 | $3,806 | $23 |
| Tolterodine Tartrate Er | 13 | $3,427 | $264 |
| Oxybutynin Chloride Er | 58 | $2,744 | $47 |
| Methenamine Hippurate | 26 | $1,997 | $77 |
| Bethanechol Chloride | 19 | $1,904 | $100 |
| Dutasteride | 18 | $1,672 | $93 |
| Nitrofurantoin | 21 | $848 | $40 |
| Nitrofurantoin Mono-Macro | 35 | $762 | $22 |
| Cephalexin | 37 | $486 | $13 |
| Alfuzosin Hcl Er | 14 | $485 | $35 |
| Oxybutynin Chloride | 24 | $358 | $15 |
| Terazosin | 12 | $330 | $27 |
| Amoxicillin-Clavulanate Potass | 25 | $223 | $9 |
| Ciprofloxacin | 31 | $215 | $7 |
| Sulfamethoxazole-Trimethoprim | 24 | $177 | $7 |
| Sildenafil Citrate | 15 | $99 | $7 |
| Levofloxacin | 13 | $45 | $3 |
Money from drug and device companies
$282 in 2023
A payment is not proof that care is biased.
| Astellas Pharma US | Xtandi | $188 | 5 payments
|
| Pfizer | Xtandi | $30 | 1 payment
|
| Boston Scientific | Solyx Sis System | $26 | 1 payment
|
| Axonics | Bulkamid | $23 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $16 | 1 payment
|
See all 9 published payments
| Astellas Pharma US | Meals · 2023-07-18 | Xtandi | $23 |
| Astellas Pharma US | Education · 2023-07-18 | None | $100 |
| Astellas Pharma US | Meals · 2023-06-20 | Xtandi | $20 |
| Boston Scientific | Meals · 2023-05-25 | Solyx Sis System | $26 |
| Astellas Pharma US | Meals · 2023-05-11 | Xtandi | $21 |
| Pfizer | Meals · 2023-04-25 | Xtandi | $30 |
| Astellas Pharma US | Meals · 2023-04-20 | Xtandi | $24 |
| Bayer Healthcare Pharmaceuticals | Meals · 2023-04-13 | Nubeqa | $16 |
| Axonics | Meals · 2023-03-15 | Bulkamid | $23 |
Professional record
- NPI
- 1326706417
- Licence
- CA 60533California G60533: Revoked
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 11053 Verve Dr, Rancho Cucamonga, CA, 91730
- NPI first listed
- 2021-12-06
- NPI last updated
- 2025-10-23
- NPI record certified
- 2025-10-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1516 San Pablo St Fl 5, Los Angeles, CA, 90033 · 365 Hawthorne Ave Ste 103, Oakland, CA, 94609 · 12401 Washington Blvd, Whittier, CA, 90602
This office lists an electronic records connection.